Exploring the causal pathway from gut microbiota to polycystic ovary syndrome: A network Mendelian randomization study

Xueyan Gao,Huijuan Zhao,Qingling Shi,Ting Zou,Yidan Zhu

DOI: https://doi.org/10.1097/md.0000000000040115

IF: 1.6

2024-10-30

Medicine

Abstract:Polycystic ovary syndrome (PCOS) is a common gynecological endocrine disease that affects approximately 6% to 20% of women of reproductive age. [ 1 , 2 ] And PCOS is not only related to fertility, but also a metabolic disease that reduces women's quality of life. [ 3 ] The main manifestations were irregular menstrual cycle, low or anovulation, hyperandrogenemia, and polycystic ovary changes. Studies have shown that PCOS is frequently related with metabolic disorders such as infertility, [ 4 ] cardiovascular disease, [ 5 , 6 ] insulin resistance, [ 7 , 8 ] type 2 diabetes, [ 9 ] dyslipidemia, [ 10 ] visceral obesity, [ 11 ] vascular endothelial dysfunction, [ 12 ] and mental health disorders, such as depression and anxiety. [ 13 ] At present, the pathogenesis of PCOS is not clear, and it is generally believed that genetic factors and environmental factors are the result of the combined effect. [ 14 , 15 ] The treatment is mainly based on lifestyle intervention, and symptomatic drug treatment is auxiliary. Weight management, insulin allergy agents, and androgen lowering agents are used primarily through medical or surgical interventions, and there is still a lack of effective drugs. [ 12 ]

medicine, general & internal